The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening tool with high sensitivity for screening patients with mild cognitive impairment (MCI). The authors examined the validity and reliability of the Korean version of the MoCA (MoCA-K) in elderly outpatients. The MoCA-K, a Korean version of the Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR) scale, and neuropsychological batteries were administered to 196 elderly persons (mild Alzheimer's disease [AD] = 44, MCI = 37, normal controls [NC] = 115). MoCA-K scores were highly correlated with those of MMSE and CDR. Using a cutoff score of 22/23, the MoCA-K had an excellent sensitivity of 89% and a good specificity of 84% for screening MCI. Internal consistency and test−retest reliability were good. The results obtained show that the MoCA-K is brief, reliable, and suitable for use as a screening tool to screen MCI patients in elderly outpatient clinic settings.
Petersen RC, Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58: 1985-1992.
2.
Ames D.For debate: is mild cognitive impairment a clinically useful concept? Int Psychogeriatr. 2006;18: 393-414.
3.
Davis HS, Rockwood K.Conceptualization of mild cognitive impairment: a review. Int J Geriatr Psychiatry. 2004;19:313-319.
4.
Petersen RCMild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194.
5.
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome . Arch Neurol. 1999;56:303-308.
6.
Bruscoli M., Lovestone S.Is MCI really just early dementia? A systematic review of conversion studies . Int Psychogeriatr. 2004;16:129-140.
7.
Dubois B., Albert MLAmnestic MCI or prodromal Alzheimer's disease? Lancet Neurol . 2004;3:246-248.
8.
Petersen RC, Thomas RG, Grundman M., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379-2388.
9.
Rozzini L., Chilovi BV, Bertoletti E., et al. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry. 2006;21:550-555.
10.
Folstein MF, Folstein SE, McHugh PR"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189-198.
11.
Anthony JC, LeResche L., Niaz U., et al. Limits of the `mini-mental state' as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397-408.
12.
Galasko D., Klauber MR, Hofstetter CR, et al. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol. 1990;47:49-52.
13.
Xu G., Meyer JS, Thornby J., et al. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes . Int J Geriatr Psychiatry. 2002;17: 1027-1033.
14.
Kalbe E., Kessler J., Calabrese P., et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004;19:136-143.
15.
Nasreddine ZS, Phillips NA, Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
16.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association Press; 1994.
17.
Morris JCThe Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43: 2412-2414.
18.
Welsh KA, Butters N., Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609-614.
19.
Lee DY, Lee KW, Lee JH, et al. A normative study of Mini-Mental State Examination in the Korean elderly. J Korean Neuropsychiatr Assoc. 2002 ;41:508-525.
20.
Choi SH, Na DL, Lee BH, et al. Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale. J Korean Neurol Assoc. 2001;19: 585-591.
21.
Lee JH, Lee KU, Lee DY, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci. 2002;57:P47-53.
22.
O'Connor DW , Pollitt PA, Hyde JB, et al. Do general practitioners miss dementia in elderly patients?BMJ. 1988;297:1107-1110.
23.
Wind AW, Schellevis FG, Van Staveren G., et al. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. Int J Geriatr Psychiatry. 1997;12:101-108.
24.
Henry JD, Crawford JR, Phillips LHVerbal fluency performance in dementia of the Alzheimer's type: a meta-analysis . Neuropsychologia. 2004;42:1212-1222.
25.
Cerhan JH, Ivnik RJ, Smith GE, et al. Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer's disease. Clin Neuropsychol . 2002; 16:35-42.
26.
Gladsjo JA, Schuman CC, Evans JD, et al. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6:147-178.
27.
Ratcliff G. , Ganguli M., Chandra V., et al. Effects of literacy and education on measures of word fluency. Brain Lang. 1998 ;61:115-122.
28.
Andres P.Frontal cortex as the central executive of working memory: time to revise our view. Cortex. 2003;39:871-895.
29.
Cannata AP, Alberoni M., Franceschi M., et al. Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;13:101-111.
30.
Miyake A., Emerson MJ, Friedman NPAssessment of executive functions in clinical settings: problems and recommendations . Semin Speech Lang. 2000;21:169-183.
31.
Terry RD, Katzman R.Life span and synapses: will there be a primary senile dementia? Neurobiol Aging. 2001; 22:347-348.
